Skip to main content
Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis

Endpoints for cancer clinical trials

Publication ,  Chapter
George, ; Wang, ; Pang,

Duke Scholars

Start / End Page

3 / 36

Publisher

Chapman & Hall/CRC
 

Citation

APA
Chicago
ICMJE
MLA
NLM
George, ., Wang, ., & Pang, . (n.d.). Endpoints for cancer clinical trials. In . George (Ed.), Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis (pp. 3–36). Chapman & Hall/CRC.
George, J Todd, J Todd Wang, and J Todd Pang. “Endpoints for cancer clinical trials.” In Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis, edited by J Todd George, 3–36. Chapman & Hall/CRC, n.d.
George, Wang, Pang. Endpoints for cancer clinical trials. In: George, editor. Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis. Chapman & Hall/CRC; p. 3–36.
George, J. Todd, et al. “Endpoints for cancer clinical trials.” Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis, edited by J Todd George, Chapman & Hall/CRC, pp. 3–36.
George, Wang, Pang. Endpoints for cancer clinical trials. In: George, editor. Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis. Chapman & Hall/CRC; p. 3–36.

Start / End Page

3 / 36

Publisher

Chapman & Hall/CRC